Canaccord Genuity Maintains a 'Buy' on OraSure Technologies (OSUR); Q2 Preview: Build on its Momentum
Tweet Send to a FriendGet Alerts OSUR Hot Sheet
Price: $4.34 -1.59%
Rating Summary:
11 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Rating Summary:
11 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Trade OSUR Now!
Canaccord Genuity maintains a 'Buy' on OraSure Technologies (NASDAQ: OSUR) price target of $14.00.
Analyst, Jeffrey Frelick, said, "We expect OraSure to report Q2/12 sales of $22.5M (+18%), in line with the consensus estimate, and EPS of $(0.09), matching consensus."
"We expect OSUR to build on its momentum from 2011, as we expect OSUR’s first-ever rapid CLIA-waived HCV test to result in $14M and $24M in HCV revenue in 2012 and 2013, respectively. In addition, OSUR obtained FDA approval for its HIV OTC test earlier than we forecasted. We expect OSUR can generate HIV-OTC revenue of $7M and $18M in 2013 and 2014, respectively."
For an analyst ratings summary and ratings history on OraSure Technologies click here. For more ratings news on OraSure Technologies click here.
Shares of OraSure Technologies closed at $12.51 yesterday, with a 52 week range of $6.29-$14.01.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Jeffrey Frelick, said, "We expect OraSure to report Q2/12 sales of $22.5M (+18%), in line with the consensus estimate, and EPS of $(0.09), matching consensus."
"We expect OSUR to build on its momentum from 2011, as we expect OSUR’s first-ever rapid CLIA-waived HCV test to result in $14M and $24M in HCV revenue in 2012 and 2013, respectively. In addition, OSUR obtained FDA approval for its HIV OTC test earlier than we forecasted. We expect OSUR can generate HIV-OTC revenue of $7M and $18M in 2013 and 2014, respectively."
For an analyst ratings summary and ratings history on OraSure Technologies click here. For more ratings news on OraSure Technologies click here.
Shares of OraSure Technologies closed at $12.51 yesterday, with a 52 week range of $6.29-$14.01.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Jefferies Bumps Zumiez (ZUMZ) Numbers Up, But Remains on Sidelines
- Williams-Sonoma (WSM) Delivers 'Clean' Q1 Beat - Analyst
- Hewlett-Packard (HPQ) Q2 Performance Wins Praise on Wall Street; Jefferies Raises to Hold
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS ViewRelated Entities
Canaccord Genuity
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
